Home >> Pharmaceuticals >> Food & Beverage >>

BioArctic Neuroscience AB - Product Pipeline Review - 2015

Published: Apr-2015 | Format: PDF | Global Markets Direct | Number of pages: 27 | Code: MRS - 18296

BioArctic Neuroscience AB - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘BioArctic Neuroscience AB - Product Pipeline Review - 2015’, provides an overview of the BioArctic Neuroscience AB’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of BioArctic Neuroscience AB’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of BioArctic Neuroscience AB including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of BioArctic Neuroscience AB’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the BioArctic Neuroscience AB’s pipeline products

Reasons to buy

- Evaluate BioArctic Neuroscience AB’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of BioArctic Neuroscience AB in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the BioArctic Neuroscience AB’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of BioArctic Neuroscience AB and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of BioArctic Neuroscience AB
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of BioArctic Neuroscience AB and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
BioArctic Neuroscience AB Snapshot 4
BioArctic Neuroscience AB Overview 4
Key Information 4
Key Facts 4
BioArctic Neuroscience AB - Research and Development Overview 5
Key Therapeutic Areas 5
BioArctic Neuroscience AB - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Out-Licensed Products 9
Out-Licensed Products/Combination Treatment Modalities 10
BioArctic Neuroscience AB - Pipeline Products Glance 11
BioArctic Neuroscience AB - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
BioArctic Neuroscience AB - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
BioArctic Neuroscience AB - Drug Profiles 14
SC-0806 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
BAN-0805 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
BAN-2502 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
AD-1502 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
BioArctic Neuroscience AB - Pipeline Analysis 19
BioArctic Neuroscience AB - Pipeline Products by Target 19
BioArctic Neuroscience AB - Pipeline Products by Route of Administration 20
BioArctic Neuroscience AB - Pipeline Products by Molecule Type 21
BioArctic Neuroscience AB - Pipeline Products by Mechanism of Action 22
BioArctic Neuroscience AB - Recent Pipeline Updates 23
BioArctic Neuroscience AB - Dormant Projects 24
BioArctic Neuroscience AB - Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 26
Disclaimer 27

List of Tables
BioArctic Neuroscience AB, Key Information 4
BioArctic Neuroscience AB, Key Facts 4
BioArctic Neuroscience AB - Pipeline by Indication, 2015 6
BioArctic Neuroscience AB - Pipeline by Stage of Development, 2015 7
BioArctic Neuroscience AB - Monotherapy Products in Pipeline, 2015 8
BioArctic Neuroscience AB - Out-Licensed Products in Pipeline, 2015 9
BioArctic Neuroscience AB - Out-Licensed Products/ Combination Treatment Modalities, 2015 10
BioArctic Neuroscience AB - Phase II, 2015 11
BioArctic Neuroscience AB - Preclinical, 2015 12
BioArctic Neuroscience AB - Discovery, 2015 13
BioArctic Neuroscience AB - Pipeline by Target, 2015 19
BioArctic Neuroscience AB - Pipeline by Route of Administration, 2015 20
BioArctic Neuroscience AB - Pipeline by Molecule Type, 2015 21
BioArctic Neuroscience AB - Pipeline Products by Mechanism of Action, 2015 22
BioArctic Neuroscience AB - Recent Pipeline Updates, 2015 23
BioArctic Neuroscience AB - Dormant Developmental Projects,2015 24

List of Figures
BioArctic Neuroscience AB - Pipeline by Top 10 Indication, 2015 6
BioArctic Neuroscience AB - Pipeline by Stage of Development, 2015 7
BioArctic Neuroscience AB - Monotherapy Products in Pipeline, 2015 8
BioArctic Neuroscience AB - Out-Licensed Products in Pipeline, 2015 9
BioArctic Neuroscience AB - Pipeline by Top 10 Target, 2015 19
BioArctic Neuroscience AB - Pipeline by Top 10 Molecule Type, 2015 21
BioArctic Neuroscience AB - Pipeline Products by Top 10 Mechanism of Action, 2015 22

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing